WAT

Waters Corporation

HealthcareDiagnostics & ResearchNASDAQ

$383.57

+$47.90 (12.49%)today

Conviction

4/ 10

Fair Value$392.68

Upside+2.38%

Signal0.95

Market Cap$29.7B

52W Range$275.05–$414.15

Next EarningsMay 5

Conviction History

Conviction Changes

Mar 18, 2026, 5:05 PM6→4conviction-rescore

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 3,000 runs · 99% valid

Fair Value$90.28

Current Price$290.02

Upside / Down-68.9%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)100.0%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

32.4%/yr

±4.3% · revenue growth to justify current price

FCF-Based Reverse DCF

39.7%/yr

±3.6% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 3

Conviction: unchanged

Waters 10-K (FY2025): BD Biosciences Acquisition Deep Dive

Waters completes .8B BD Biosciences acquisition (Feb 2026). Transforms from pure analytical instruments to diversified life sciences platform. B new debt requires Q1 2026 refinancing. M revenue + M co...